NVIDIA takes stakes in Doctolib, Pigment, Genesis AI and Entalpic
During a visit to Paris on October 13, Jensen Huang announced equity stakes in four French AI startups, including Doctolib. The amounts were not disclosed.
Translated from French by AI. The original French article is the reference version.
NVIDIA announced on October 13, during a visit to Paris by its CEO Jensen Huang, equity stakes in four French startups: Doctolib, Pigment, Genesis AI and Entalpic. The American chipmaker refers to "planned investments" in a blog post published for the occasion. No amount was officially disclosed.
Doctolib, the most visible stake
At Doctolib, NVIDIA is taking a minority stake. According to Le Figaro, as cited by Next, it would amount to a few million euros. That is small compared with the €3.6 billion valuation set in April, during a sale of shares held by employees and early investors, according to Maddyness. Doctolib CEO Stanislas Niox-Chateau says the money will help "accelerate our hiring and our AI development."
Doctolib has been training its own models on NVIDIA technology for about a year. These models power assistants for health care professionals (consultation, billing, secretarial work, medical coding) and a personal assistant for patients. Tested by 400,000 people in France, the latter is due to be offered to everyone in 2027. According to Next, Doctolib says the funds will go to open models and European infrastructure.
Robots, materials and planning
The other three companies work in very different fields. Genesis AI builds general-purpose robots based on foundation models and simulation. Entalpic, based in Paris, designs materials at the atomic scale, notably for semiconductors. Pigment publishes planning and forecasting software for businesses. According to Maddyness, Jensen Huang said NVIDIA invested at least $8 billion in Europe last year and planned a further $2 billion this year. NVIDIA's blog post, for its part, mentions nearly $10 billion committed to the European technology ecosystem.
Key takeaways
At least one of these companies, Doctolib, is already an NVIDIA customer, which means NVIDIA is becoming a shareholder of a leading European client. For IT departments, the announcement confirms the American group's weight in European AI, at a time when Doctolib is emphasizing sovereignty. Next points out that Doctolib has been using data for its AI research since July without asking for users' consent, an issue to watch in the sensitive field of health care. NVIDIA's GTC conference in Berlin, starting October 21, could bring further European announcements.
Method: AI-assisted monitoring, verified sources, article reviewed and approved by Frédéric LENQUETTE.
Share this article
